The "Capillary Blood Collection Devices Market Size, Share & Trends Analysis By Material, By Product, By End-use, By Application, By Region, And Segment Forecasts, 2025-2030" report has been added to ...

The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other ...

From unusual cravings to unexplained fatigue, discover the hidden signs of iron deficiency and learn how to protect your health with expert-approved solutions.

Ozone (O3) exposure may reduce the availability of oxygen in the body, resulting in arterial stiffening due to the body’s natural response to create more red blood cells and hemoglobin, according ...

Below-zero temperatures are a good excuse to find useful things to do indoors, so here’s an idea: Donate a pint of blood.

Ozone (O3) exposure may reduce the availability of oxygen in the body, resulting in arterial stiffening due to the body's ...

Ozone (O3) exposure may reduce the availability of oxygen in the body, resulting in arterial stiffening due to the body's natural response to create ...

Ozone (O3) exposure may reduce the availability of oxygen in the body, resulting in arterial stiffening due to the body's natural response to create more red blood cells and hemoglobin, according to a ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...

IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...